Spearhead Capital Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,472
| Closed | -$316K | – | 188 |
|
|
2022
Q1 | $316K | Sell |
2,472
-2,116
| -46% | -$270K | 0.04% | 125 |
|
|
2021
Q4 | $616K | Buy |
4,588
+8
| +0.2% | +$1.07K | 0.07% | 83 |
|
|
2021
Q3 | $626K | Buy |
4,580
+44
| +1% | +$6.01K | 0.08% | 78 |
|
|
2021
Q2 | $484K | Buy |
4,536
+472
| +12% | +$50.4K | 0.07% | 105 |
|
|
2021
Q1 | $365K | Buy |
4,064
+168
| +4% | +$15.1K | 0.05% | 112 |
|
|
2020
Q4 | $360K | Buy |
3,896
+144
| +4% | +$13.3K | 0.06% | 127 |
|
|
2020
Q3 | $387K | Buy |
3,752
+168
| +5% | +$17.3K | 0.07% | 97 |
|
|
2020
Q2 | $363K | Buy |
3,584
+504
| +16% | +$51K | 0.08% | 85 |
|
|
2020
Q1 | $207K | Buy |
+3,080
| New | +$207K | 0.06% | 95 |
|